![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ELP5 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:1615924 | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELP5 mRNA | CTD | PMID:22206623 | ELP5 | Human | 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1303303 | 6480464 | Ethinyl Estradiol results in decreased expression of ELP5 mRNA | CTD | PMID:17557909 | ELP5 | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of ELP5 protein | CTD | PMID:33181973 | ELP5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1303303 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ELP5 mRNA | CTD | PMID:21215274 | ELP5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1303303 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ELP5 mRNA | CTD | PMID:33387578 | ELP5 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1615924 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ELP5 mRNA | CTD | PMID:21570461|PMID:24680724 | ELP5 | Human | 2,4-dinitrotoluene | affects expression | ISO | RGD:1303303 | 6480464 | 2,4-dinitrotoluene affects the expression of ELP5 mRNA | CTD | PMID:21346803 | ELP5 | Human | 2,6-dinitrotoluene | affects expression | ISO | RGD:1303303 | 6480464 | 2,6-dinitrotoluene affects the expression of ELP5 mRNA | CTD | PMID:21346803 | ELP5 | Human | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1615924 | 6480464 | bisphenol S results in increased expression of ELP5 mRNA | CTD | PMID:39298647 | ELP5 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1615924 | 6480464 | bisphenol S affects the methylation of ELP5 gene | CTD | PMID:31683443 | ELP5 | Human | 6-propyl-2-thiouracil | increases expression | ISO | RGD:1303303 | 6480464 | Propylthiouracil results in increased expression of ELP5 mRNA | CTD | PMID:30047161 | ELP5 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | ELP5 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of ELP5 mRNA | CTD | PMID:33167477 | ELP5 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | ELP5 | Human | amitrole | increases expression | ISO | RGD:1303303 | 6480464 | Amitrole results in increased expression of ELP5 mRNA | CTD | PMID:30047161 | ELP5 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of ELP5 mRNA | CTD | PMID:33212167 | ELP5 | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP5 more ... | CTD | PMID:39836092 | ELP5 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP5 more ... | CTD | PMID:39836092 | ELP5 | Human | arsenous acid | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of ELP5 mRNA | CTD | PMID:22521957 | ELP5 | Human | benzo[a]pyrene | increases expression | ISO | RGD:1615924 | 6480464 | Benzo(a)pyrene results in increased expression of ELP5 mRNA | CTD | PMID:22228805 | ELP5 | Human | beta-lapachone | decreases expression | EXP | | 6480464 | beta-lapachone results in decreased expression of ELP5 mRNA | CTD | PMID:38218311 | ELP5 | Human | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1615924 | 6480464 | Diethylhexyl Phthalate results in increased expression of ELP5 mRNA | CTD | PMID:33754040 | ELP5 | Human | bisphenol A | increases expression | ISO | RGD:1303303 | 6480464 | bisphenol A results in increased expression of ELP5 mRNA | CTD | PMID:25181051|PMID:32145629 | ELP5 | Human | bisphenol A | increases expression | ISO | RGD:1615924 | 6480464 | bisphenol A results in increased expression of ELP5 mRNA | CTD | PMID:33221593 | ELP5 | Human | bisphenol A | increases methylation | ISO | RGD:1303303 | 6480464 | bisphenol A results in increased methylation of ELP5 gene | CTD | PMID:28505145 | ELP5 | Human | bortezomib | decreases expression | EXP | | 6480464 | Bortezomib results in decreased expression of ELP5 mRNA | CTD | PMID:20977926 | ELP5 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELP5 more ... | CTD | PMID:35301059 | ELP5 | Human | cadmium dichloride | increases methylation | ISO | RGD:1303303 | 6480464 | Cadmium Chloride results in increased methylation of ELP5 promoter | CTD | PMID:22457795 | ELP5 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ELP5 more ... | CTD | PMID:35301059 | ELP5 | Human | cadmium dichloride | decreases expression | ISO | RGD:1303303 | 6480464 | Cadmium Chloride results in decreased expression of ELP5 mRNA | CTD | PMID:33453195 | ELP5 | Human | carbon nanotube | increases expression | ISO | RGD:1615924 | 6480464 | Nanotubes, Carbon results in increased expression of ELP5 mRNA | CTD | PMID:25554681 | ELP5 | Human | chlorpyrifos | increases expression | ISO | RGD:1615924 | 6480464 | Chlorpyrifos results in increased expression of ELP5 mRNA | CTD | PMID:37019170 | ELP5 | Human | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of ELP5 mRNA | CTD | PMID:19376846 | ELP5 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA | CTD | PMID:19167446 | ELP5 | Human | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of ELP5 mRNA | CTD | PMID:19167446 | ELP5 | Human | diarsenic trioxide | increases expression | EXP | | 6480464 | Arsenic Trioxide results in increased expression of ELP5 mRNA | CTD | PMID:22521957 | ELP5 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of ELP5 mRNA | CTD | PMID:37042841 | ELP5 | Human | dibutyl phthalate | increases expression | ISO | RGD:1303303 | 6480464 | Dibutyl Phthalate results in increased expression of ELP5 mRNA | CTD | PMID:21266533 | ELP5 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ELP5 mRNA | CTD | PMID:29803840 | ELP5 | Human | ethanol | affects splicing | ISO | RGD:1615924 | 6480464 | Ethanol affects the splicing of ELP5 mRNA | CTD | PMID:30319688 | ELP5 | Human | flutamide | increases expression | ISO | RGD:1303303 | 6480464 | Flutamide results in increased expression of ELP5 mRNA | CTD | PMID:24136188 | ELP5 | Human | folic acid | multiple interactions | ISO | RGD:1615924 | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ELP5 mRNA | CTD | PMID:22206623 | ELP5 | Human | gentamycin | increases expression | ISO | RGD:1303303 | 6480464 | Gentamicins results in increased expression of ELP5 mRNA | CTD | PMID:33387578 | ELP5 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of ELP5 protein | CTD | PMID:32959892 | ELP5 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of ELP5 mRNA | CTD | PMID:28988120 | ELP5 | Human | methimazole | increases expression | ISO | RGD:1303303 | 6480464 | Methimazole results in increased expression of ELP5 mRNA | CTD | PMID:30047161 | ELP5 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of more ... | CTD | PMID:32699268 | ELP5 | Human | paracetamol | affects expression | ISO | RGD:1615924 | 6480464 | Acetaminophen affects the expression of ELP5 mRNA | CTD | PMID:17562736 | ELP5 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ELP5 mRNA | CTD | PMID:19167446 | ELP5 | Human | sodium arsenite | multiple interactions | EXP | | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ELP5 more ... | CTD | PMID:39836092 | ELP5 | Human | Soman | increases expression | ISO | RGD:1303303 | 6480464 | Soman results in increased expression of ELP5 mRNA | CTD | PMID:19281266 | ELP5 | Human | sulfadimethoxine | increases expression | ISO | RGD:1303303 | 6480464 | Sulfadimethoxine results in increased expression of ELP5 mRNA | CTD | PMID:30047161 | ELP5 | Human | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of ELP5 mRNA | CTD | PMID:17440010 | ELP5 | Human | tetrachloromethane | increases expression | ISO | RGD:1615924 | 6480464 | Carbon Tetrachloride results in increased expression of ELP5 mRNA | CTD | PMID:31919559 | ELP5 | Human | thioacetamide | increases expression | ISO | RGD:1303303 | 6480464 | Thioacetamide results in increased expression of ELP5 mRNA | CTD | PMID:34492290 | ELP5 | Human | triptonide | affects expression | ISO | RGD:1615924 | 6480464 | triptonide affects the expression of ELP5 mRNA | CTD | PMID:33045310 | ELP5 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ELP5 mRNA | CTD | PMID:25979313 | ELP5 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of ELP5 mRNA | CTD | PMID:29154799 | ELP5 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ELP5 mRNA | CTD | PMID:23179753|PMID:24935251|PMID:27188386 | |